Tejara Capital Ltd

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1879713 LONDON, X0

Position in ARQT

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$3,915,459

-$5,896,022 QoQ

Shares Held

166,191

-68.1% QoQ

Ownership

0.133%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Tejara Capital Ltd holds $25,474,690 across 8 Biotechnology names. ARQT ranks #3 (15.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	3,495,187	$9,891,379
2	HRTX	Heron Therapeutics, Inc. /De/	6,336,755	$5,069,404
3	ARQT	Arcutis Biotherapeutics, Inc. This page	166,191	$3,915,459
4	QURE	uniQure N.V.	122,092	$1,996,204
5	SPRY	ARS Pharmaceuticals, Inc.	210,400	$1,689,512
6	VIR	Vir Biotechnology, Inc.	161,789	$1,449,629
7	VKTX	Viking Therapeutics, Inc.	24,300	$790,722
8	MREO	Mereo BioPharma Group plc	2,037,520	$672,381

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,915,459	166,191	-68.1%	Shares	Sole	2026-05-12
2025-09-30	$9,811,481	520,503	-40.4%	Shares	Sole	2025-11-04
2025-06-30	$12,244,801	873,381	+3.2%	Shares	Sole	2025-08-13
2025-03-31	$13,234,896	846,221	-4.6%	Shares	Sole	2025-05-13
2024-12-31	$12,353,653	886,838	-23.9%	Shares	Sole	2025-02-10
2024-09-30	$10,837,373	1,165,309	-13.3%	Shares	Sole	2024-11-13
2024-06-30	$12,495,563	1,343,609	+42.9%	Shares	Sole	2024-08-14
2024-03-31	$9,320,226	940,487	-15.4%	Shares	Sole	2024-05-14
2023-12-31	$3,592,460	1,112,217	+259.7%	Shares	Sole	2024-02-12
2023-09-30	$1,641,740	309,179	+88.3%	Shares	Sole	2023-11-15
2023-06-30	$1,564,625	164,179	+67.5%	Shares	Sole	2023-08-11
2023-03-31	$1,078,000	98,000	+69.0%	Shares	Sole	2023-05-12
2022-12-31	$858,400	58,000	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.